A relationship between lupus autoimmunity, myeloproliferative disorders and calreticulin mutations is reminiscent of the incidence of scleroderma in cancer patients with RNA polymerase IIIA mutations (Joseph et al., 2014). This evidence concerns the gene CALR and cancer.